A 7-year follow-up study of ninety patients with psoriasis.
D000287:Administration, Topical; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D000553:Ambulatory Care; D001623:Betamethasone / Q000627:therapeutic use; D005260:Female; D005500:Follow-Up Studies; D006701:Home Nursing; D006760:Hospitalization; D006801:Humans; D008297:Male; D011379:Prognosis; D011565:Psoriasis / Q000188:drug therapy* / Q000532:radiotherapy / Q000628:therapy*; D012075:Remission, Spontaneous; D012459:Salicylates / Q000627:therapeutic use; D013638:Tars / Q000627:therapeutic use; D013997:Time Factors; D014467:Ultraviolet Therapy
D000305:Adrenal Cortex Hormones; D012459:Salicylates; D013638:Tars; D001623:Betamethasone